PMID: 20700710

Wakabayashi-Nakao K, Tamura A, Koshiba S, Toyoda Y, Nakagawa H, Ishikawa T
Production of cells with targeted integration of gene variants of human ABC transporter for stable and regulated expression using the Flp recombinase system.
Methods Mol Biol. 2010;648:139-59., [PubMed]
Sentences
No. Mutations Sentence Comment
34 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 20700710:34:84
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:34:91
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:34:102
status: VERIFIED
view ABCG2 p.Ser441Asn details
Furthermore, certain non-synonymous single nucleotide polymorphisms (SNPs), such as Q141K, F208S, and S441N, were also found to greatly affect the stability of ABCG2 in the ER and to enhance the protein degradation rate via ubiquitination and proteasomal proteolysis in Flp-In-293 cells (22-27) (Fig. 1). Login to comment
226 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:226:137
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:226:147
status: VERIFIED
view ABCG2 p.Ser441Asn details
It was of great interest to know how the inhibition of proteasomal protein degradation by MG132 affects the cellular localization of the F208S and S441N variant proteins (see Notes 5 and 6). Login to comment
227 ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:227:86
status: VERIFIED
view ABCG2 p.Ser441Asn details
Figure 6a depicts the immunofluorescence images of Flp-In-293 cells expressing ABCG2 S441N that were incubated with or without 2 mM MG132 for 24 h. Login to comment
228 ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:228:19
status: VERIFIED
view ABCG2 p.Ser441Asn details
In the case of the S441N 3.3.4. Login to comment
245 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:245:141
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:245:151
status: VERIFIED
view ABCG2 p.Ser441Asn details
Figure 3a depicts a schematic illustration of the human ABCG2 protein to indicate the sites of amino acid alteration in the SNP variants of F208S and S441N. Login to comment
247 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:247:8
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:247:19
status: VERIFIED
view ABCG2 p.Ser441Asn details
Notes F208S, and S441N were individually expressed in Flp-In-293 cells by using the Flp recombinase system. Login to comment
248 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:248:56
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:248:66
status: VERIFIED
view ABCG2 p.Ser441Asn details
As shown in Fig. 3b, mRNA levels of ABCG2 WT as well as F208S and S441N were evenly represented in Flp-In-293 cells, where the mRNA levels of ABCG2 and GAPDH were measured by RT-PCR. Login to comment
249 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:249:29
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:249:40
status: VERIFIED
view ABCG2 p.Ser441Asn details
On the other hand, ABCG2 WT, F208S, and S441N as well as GAPDH proteins were detected by immunoblotting, and their expression levels were quantified. Login to comment
253 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:253:77
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:253:88
status: VERIFIED
view ABCG2 p.Ser441Asn details
Schematic illustration of human ABCG2 as well as the expression of ABCG2 WT, F208S, and S441N in Flp-In-293 cells at the mRNA and protein levels. Login to comment
254 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:254:63
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:254:126
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:254:77
status: VERIFIED
view ABCG2 p.Ser441Asn details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:254:136
status: VERIFIED
view ABCG2 p.Ser441Asn details
(a) Arrows indicate the positions of amino acid substitutions (Phe208Ser and Ser441Asn) in the non-synonymous SNP variants of F208S and S441N. Login to comment
259 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:259:110
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:259:120
status: VERIFIED
view ABCG2 p.Ser441Asn details
(b) The mRNA level was analyzed by RT-PCR with total RNA extracted from Flp-In-293 cells expressing ABCG2 WT, F208S, or S441N. Login to comment
265 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:265:70
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:265:80
status: VERIFIED
view ABCG2 p.Ser441Asn details
Although mRNA levels were almost the same in the WT and SNP variants (F208S and S441N), protein levels of those variants were markedly decreased (Fig. 3d). Login to comment
268 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:268:83
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:268:94
status: VERIFIED
view ABCG2 p.Ser441Asn details
Figure 4a shows the effect of ME treatments on the SDS-PAGE migration of ABCG2 WT, F208S, and S441N proteins. Login to comment
270 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:270:34
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:270:45
status: VERIFIED
view ABCG2 p.Ser441Asn details
Immunoblot detection of ABCG2 WT, F208S, and S441N proteins expressed in Flp-In-293 cells. Login to comment
271 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:271:236
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:271:247
status: VERIFIED
view ABCG2 p.Ser441Asn details
(a) Effect of mercaptoethanol (ME) on the status (homodimer or monomer) of ABCG2 WT and the SNP variants. Cell lysate samples (20 mg of protein) were subjected to SDS-PAGE after treatments with or without ME; and, thereafter, ABCG2 WT, F208S, and S441N proteins were detected by immunoblotting with the BXP-21 antibody, as described in Subheading 3.3.3. Login to comment
272 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:272:28
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:272:39
status: VERIFIED
view ABCG2 p.Ser441Asn details
By ME treatments, ABCG2 WT, F208S, and S441N proteins were changed from homodimers to monomers. Login to comment
273 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:273:225
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:273:236
status: VERIFIED
view ABCG2 p.Ser441Asn details
(b) Effect of Endo H or PNGase F treatments on the glycosylated status of ABCG2 WT and the SNP variants. Cell lysate samples (20 mg of protein) were treated with Endo H or PNGase F, as described in Subheading 3.3.3.ABCG2 WT, F208S, and S441N proteins in the resulting samples were analyzed by immunoblotting with the BXP-21 antibody.The apparent molecular weights of mature and non-glycosylated ABCG2 WT were 81,000 and 72,000, respectively. Login to comment
280 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:280:36
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:280:46
status: VERIFIED
view ABCG2 p.Ser441Asn details
These results provide evidence that F208S and S441N proteins form homodimers through a cysteinyl disulfide bond as does the ABCG2 WT protein. Login to comment
284 ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:284:27
status: VERIFIED
view ABCG2 p.Ser441Asn details
On the other hand, for the S441N variant, two protein bands of ABCG2 were detected around the molecular weight of 81,000. Login to comment
285 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:285:19
status: VERIFIED
view ABCG2 p.Phe208Ser details
In the case of the F208S variant, one faint band was detected at the apparent molecular weight of 74,000 by the same sample processing and immunoblotting experiment. Login to comment
289 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:289:178
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:289:218
status: VERIFIED
view ABCG2 p.Ser441Asn details
Although the major band (M.W. = 81,000) of ABCG2 WT was not at all affected by the Endo H treatment, the apparent molecular weights of the smaller protein bands of F208S (M.W. = 74,000) and S441N (M.W. = 78,000) decreased after the Endo H treatment. Login to comment
292 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:292:145
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:292:155
status: VERIFIED
view ABCG2 p.Ser441Asn details
The matured N-linked oligosaccharide of ABCG2 WT may have a structure resistant to Endo H, whereas the immature N-linked oligosaccharides of the F208S and S441N variant proteins are susceptible to this endoglycosidase. Login to comment
295 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:295:28
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:295:37
status: VERIFIED
view ABCG2 p.Ser441Asn details
Flp-In-293 cells expressing F208S or S441N were incubated in the presence of MG132 at different concentrations (0, 0.4, 2.0 mM) for 24 h, and then cell lysate samples were immediately prepared. Login to comment
296 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:296:33
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:296:43
status: VERIFIED
view ABCG2 p.Ser441Asn details
Protein expression levels of the F208S and S441N variants were determined by immunoblotting after PNGase F treatments in the same way as described above. Login to comment
299 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:299:42
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:299:52
status: VERIFIED
view ABCG2 p.Ser441Asn details
After the 24-h treatment with 2 mM MG132, F208S and S441N protein levels were increased 12-and 6-fold, respectively. Login to comment
301 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:301:73
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:301:83
status: VERIFIED
view ABCG2 p.Ser441Asn details
Effects of MG132 on the glycosylation status and protein levels of ABCG2 F208S and S441N variants expressed in Flp-In-293 cells. Login to comment
302 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:302:22
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:302:51
status: VERIFIED
view ABCG2 p.Ser441Asn details
(a) Flp-In-293/ABCG2 (F208S) and Flp-In-293/ABCG2 (S441N) cells were incubated with MG132 at concentrations of 0, 0.4, 2 mM for 24 h. Login to comment
304 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:304:6
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:304:231
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:304:16
status: VERIFIED
view ABCG2 p.Ser441Asn details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:304:240
status: VERIFIED
view ABCG2 p.Ser441Asn details
ABCG2 F208S and S441N variant proteins were analyzed by immunoblotting with the ABCG2-specific monoclonal antibody (BXP-21) either directly or after PNGase F treatment.The signal intensity of the non-glycosylated form of the ABCG2 F208S or S441N variant was measured after PNGase F treatment.The intensities are represented as ratios relative to the ABCG2 level in MG132-untreated cells. Login to comment
308 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:308:74
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:308:84
status: VERIFIED
view ABCG2 p.Ser441Asn details
(b) Detection of aggregated forms (M.W. > 200,000) of ABCG2 F208S and S441N variants. Login to comment
309 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:309:18
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:309:48
status: VERIFIED
view ABCG2 p.Ser441Asn details
Flp-In-293/ABCG2 (F208S) and Flp-In-293/ ABCG2 (S441N) cells were incubated with MG132 at concentrations of 0, 0.4, 2 mM for 24 h. Login to comment
310 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:310:81
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:310:91
status: VERIFIED
view ABCG2 p.Ser441Asn details
Cell lysate samples (20 mg of protein) were prepared in the presence of ME.ABCG2 F208S and S441N variant proteins were prepared from MG132-treated cells as described above and analyzed by immunoblotting with the BXP-21 antibody without PNGase F treatment. Login to comment
311 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:311:30
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:311:40
status: VERIFIED
view ABCG2 p.Ser441Asn details
The aggregated forms of ABCG2 F208S and S441N are indicated by arrowheads. Login to comment
315 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:315:61
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:315:71
status: VERIFIED
view ABCG2 p.Ser441Asn details
non-glycosylated form (M.W. = 72,000) for both F208S and S441N variants, where those cell lysate samples were not treated with PNGase F (Fig. 5a). Login to comment
316 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:316:139
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:316:149
status: VERIFIED
view ABCG2 p.Ser441Asn details
More importantly, upon the immunoblot analysis without PNGase F treatments, aggregated forms (indicated by arrowheads in Fig. 5b) of both F208S and S441N variants were detected in the high molecular weight range of over 200,000. Login to comment
318 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:318:137
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:318:147
status: VERIFIED
view ABCG2 p.Ser441Asn details
It was of great interest to know how the inhibition of proteasomal protein degradation by MG132 affects the cellular localization of the F208S and S441N variant proteins. Login to comment
319 ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:319:86
status: VERIFIED
view ABCG2 p.Ser441Asn details
Figure 6a depicts the immunofluorescence images of Flp-In-293 cells expressing ABCG2 S441N that were incubated with or without 2 mM MG132 for 24 h. Login to comment
320 ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:320:19
status: VERIFIED
view ABCG2 p.Ser441Asn details
In the case of the S441N variant, MG132 treatments enhanced the localization of the ABCG2 variant protein at the plasma membrane and in intracellular compartments. By immunoelectron microscopy, we could detect ABCG2 aggresome formation adjacent to the nuclei when Flp-In-293 cells expressing the F208 variant were treated with 2 mM MG132 for 24 h (Fig. 6b). Login to comment
323 ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 20700710:323:157
status: VERIFIED
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 20700710:323:65
status: VERIFIED
view ABCG2 p.Ser441Asn details
Immunocytochemical staining of Flp-In-293 cells expressing ABCG2 S441N protein (a) and immunoelectron microscopic image of Flp-In-293 cells expressing ABCG2 F208S protein (b). Login to comment